Immunotherapy and pulmonary toxicities: can concomitant immune-checkpoint inhibitors with radiotherapy increase the risk of radiation pneumonitis?

Guillaume Louvel, Rastislav Bahleda, Samy Ammari, Cécile Le Péchoux, Antonin Levy, Christophe Massard, Jérôme Le Pavec, Stéphane Champiat, Eric Deutsch

Source: Eur Respir J, 51 (1) 1701737; 10.1183/13993003.01737-2017
Journal Issue: January
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Guillaume Louvel, Rastislav Bahleda, Samy Ammari, Cécile Le Péchoux, Antonin Levy, Christophe Massard, Jérôme Le Pavec, Stéphane Champiat, Eric Deutsch. Immunotherapy and pulmonary toxicities: can concomitant immune-checkpoint inhibitors with radiotherapy increase the risk of radiation pneumonitis?. Eur Respir J, 51 (1) 1701737; 10.1183/13993003.01737-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Hypersensitivity pneumonitis associated with the use of temozolomide
Source: Eur Respir J 2009; 33: 931-934
Year: 2009



Combination immunotherapy in mesothelioma: managing expectations and new toxicities
Source: Virtual Congress 2021 – Lung cancer grand round
Year: 2021


Thromboembolic events in lung cancer patients treated with platinum-based chemotherapy
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019


Low-dose amiodarone therapy may be responsible of serious adverse pulmonary effects in patients without pre-existing lung disease
Source: Eur Respir J 2004; 24: Suppl. 48, 280s
Year: 2004

Clinical characteristic of lung cancer patients with interstitial pneumonia treated with chemotherapy or radiotherapy
Source: Annual Congress 2008 - Therapy of thoracic tumours
Year: 2008


Hypersensitivity pneumonitis associated with temozolomide
Source: Eur Respir J 2009; 33: 526
Year: 2009


Chronic eosinophilic pneumonia after radiation therapy for breast cancer
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011

To treat or not to treat with corticosteroids radiation induced pneumonitis
Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases
Year: 2013


Role of chemotherapy and radiation therapy
Source: Annual Congress 2012 - PG10 An update on mesothelioma diagnostics and treatment
Year: 2012



Combined radiation therapy in treatment of tracheal cancers
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008


Evaluation of outpatient infections in lung cancer patients treated with chemotherapy and/or radiotherapy
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012

Predictive role of MMP-2 genetic variants on severe hematologic toxicity of NSCLC patients treated with first-line, platinum-based chemotherapy
Source: Annual Congress 2011 - Genetics of airway diseases and treatment
Year: 2011


Pneumonectomy for lung cancer after induction chemotherapy alone: Is the risk really higher?
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015

Severe fibrotic lung disease – How much therapy is too much therapy?
Source: Annual Congress 2008 - Clinical Grand Round - an interactive session
Year: 2008


Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis
Source: ERJ Open Res, 3 (3) 00016-2017; 10.1183/23120541.00016-2017
Year: 2017



Effect of statin therapy in patients with lung cancer on mortality, incidence of infections and pulmonary embolism
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012

Efficacy of a toxicity-adjusted topotecan therapy in recurrent small cell lung cancer
Source: Eur Respir J 2006; 27: 1183-1189
Year: 2006



Assessment of lung cancer related symptoms and chemotherapy related side effects in a group of patients with advanced lung cancer receiving palliative chemotherapy
Source: Eur Respir J 2006; 28: Suppl. 50, 752s
Year: 2006

The effectiveness of pegfilgrastim in preventing leucopenia in patients with lung cancer under chemotherapy
Source: Eur Respir J 2005; 26: Suppl. 49, 77s
Year: 2005